LIA
ABMD

LS Investment Advisors’s Abiomed Inc ABMD Stock Holding History

LS Investment Advisors’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,292
Closed -$412K – 777
2021
Q1 		$412K Sell
1,292
-459
-26% -$147K 0.02% 447
2020
Q4 		$568K Buy
1,751
+372
+27% +$103K 0.03% 386
2020
Q3 		$382K Sell
1,379
-66
-5% -$19K 0.02% 472
2020
Q2 		$349K Sell
1,445
-363
-20% -$72.9K 0.02% 491
2020
Q1 		$262K Sell
1,808
-248
-12% -$41.2K 0.02% 522
2019
Q4 		$351K Sell
2,056
-38
-2% -$7.04K 0.02% 608
2019
Q3 		$373K Buy
2,094
+255
+14% +$55.1K 0.02% 550
2019
Q2 		$479K Buy
1,839
+139
+8% +$36.9K 0.03% 473
2019
Q1 		$486K Buy
1,700
+86
+5% +$28.6K 0.03% 464
2018
Q4 		$525K Sell
1,614
-684
-30% -$238K 0.04% 392
2018
Q3 		$1.03M Sell
2,298
-117
-5% -$46.1K 0.06% 285
2018
Q2 		$988K Sell
2,415
-1,063
-31% -$385K 0.06% 289
2018
Q1 		$1.01M Sell
3,478
-271
-7% -$68.7K 0.06% 283
2017
Q4 		$703K Sell
3,749
-1,125
-23% -$210K 0.04% 382
2017
Q3 		$822K Buy
4,874
+437
+10% +$66.1K 0.05% 318
2017
Q2 		$636K Buy
4,437
+539
+14% +$72.4K 0.04% 400
2017
Q1 		$488K Buy
3,898
+989
+34% +$115K 0.03% 462
2016
Q4 		$328K Buy
2,909
+88
+3% +$10.2K 0.02% 596
2016
Q3 		$363K Buy
2,821
+206
+8% +$24.7K 0.03% 494
2016
Q2 		$286K Buy
2,615
+1,062
+68% +$106K 0.02% 625
2016
Q1 		$147K Buy
1,553
+130
+9% +$11K 0.01% 734
2015
Q4 		$128K Hold
1,423
– – 0.01% 776
2015
Q3 		$132K Hold
1,423
– – 0.01% 742
2015
Q2 		$94K Buy
+1,423
New +$94.5K 0.01% 908

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

LS Investment Advisors's ABMD Position: Q2 2021 in Review

LS Investment Advisors sold out of Abiomed Inc (ABMD) in Q2 2021, closing a stake of 1,292 shares — an estimated $412K sold.

LS Investment Advisors first reported a position in ABMD in Q2 2015 and held it in 24 quarters. The position peaked at $1.03M in Q3 2018. 474 funds tracked by Wall St. Rank hold ABMD as of Q2 2021.

  • LS Investment Advisors reported no remaining Abiomed Inc position as of Q2 2021 after selling out during the quarter.
  • LS Investment Advisors sold 1,292 Abiomed Inc shares in Q2 2021, an estimated $412K.
  • LS Investment Advisors first reported a position in Abiomed Inc in Q2 2015 and held it in 24 quarters.
  • LS Investment Advisors's Abiomed Inc position peaked at $1.03M in Q3 2018.
  • 474 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2021.

Based on LS Investment Advisors's 13F filing for Q2 2021, filed 11 Aug 2021.